Informed Momentum Co LLC Purchases Shares of 41,398 Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Informed Momentum Co LLC has made a new investment of approximately $3.56 million in Prestige Consumer Healthcare, acquiring 41,398 shares during the first quarter.
• Prestige Consumer Healthcare reported a quarterly EPS of $0.95, below analysts' expectations, with revenue down 6.6% year-over-year.
• Equities research analysts have mixed ratings on Prestige Consumer Healthcare, with price targets ranging from a downgrade to "hold" by Wall Street Zen to a maintained "buy" rating by Canaccord Genuity Group.

Informed Momentum Co LLC bought a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 41,398 shares of the company's stock, valued at approximately $3,559,000. Informed Momentum Co LLC owned 0.08% of Prestige Consumer Healthcare as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC increased its position in shares of Prestige Consumer Healthcare by 35.9% during the first quarter. GAMMA Investing LLC now owns 1,879 shares of the company's stock worth $162,000 after acquiring an additional 496 shares in the last quarter. KBC Group NV increased its position in shares of Prestige Consumer Healthcare by 7.4% during the first quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after acquiring an additional 151 shares in the last quarter. QRG Capital Management Inc. increased its position in shares of Prestige Consumer Healthcare by 8.6% during the first quarter. QRG Capital Management Inc. now owns 5,971 shares of the company's stock worth $513,000 after acquiring an additional 475 shares in the last quarter. BNP Paribas Financial Markets increased its position in shares of Prestige Consumer Healthcare by 1,073.3% during the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock worth $15,923,000 after acquiring an additional 186,524 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its position in shares of Prestige Consumer Healthcare by 14.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 8,315 shares of the company's stock worth $649,000 after acquiring an additional 1,030 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PBH has been the subject of several research reports. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, Canaccord Genuity Group decreased their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $93.33.

Prestige Consumer Healthcare Stock Down 2.8%

Prestige Consumer Healthcare stock traded down $1.83 during mid-day trading on Thursday, reaching $64.60. The company's stock had a trading volume of 648,215 shares, compared to its average volume of 385,094. The company has a market capitalization of $3.18 billion, a price-to-earnings ratio of 15.16, a price-to-earnings-growth ratio of 2.06 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 12 month low of $62.95 and a 12 month high of $90.04. The business's 50 day simple moving average is $77.67 and its 200 day simple moving average is $81.68. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The business had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm's revenue for the quarter was down 6.6% on a year-over-year basis. During the same period last year, the business posted $0.90 EPS. As a group, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.